March 10, 2021
International Dermatology Outcome Measures (IDEOM) is working to establish patient-centered measurements to enhance research and treatment of those with dermatological diseases. Our priority is to create meaningful endpoints for use in clinical trials and that can carry-over into clinical practice, taking into account the needs of patients, providers, researchers, payers and regulators.
IDEOM thanks their corporate sponsors for its support of our past meetings. We recognize the inconsistency and unmet need in current tools and measurements, and together relevant stakeholders, including clinicians, methodologists, patients, pharmaceutical colleagues, insurers, regulatory agencies and policy regulators, our goal is to address these gaps in clinical end points.
We respectfully request your corporate sponsorship support. The Corporate sponsorship packages are attached and are valid for one year (2021). The annual meeting for 2021 will be held October 22-23.
We also have the following new workgroups are joining IDEOM this year:
Cutaneous T-Cell Lymphoma
We thank you for your consideration and hope to see you at the annual meeting, where the voice of our industry stakeholders is important.
IDEOM Association Manager